AAAAAA

   
Results: 1-9 |
Results: 9
Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation
Authors: Tosi, P Ronconi, S Zamagni, E Cellini, C Grafone, T Cangini, D Pileri, SA Baccarani, M Tura, S Cavo, M
Citation: P. Tosi et al., Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood stem cell transplantation, HAEMATOLOG, 86(4), 2001, pp. 409-413
Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure
Authors: Tosi, P Zamagni, E Ronconi, S Benni, M Motta, MR Rizzi, S Tura, S Cavo, M
Citation: P. Tosi et al., Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure, LEUKEMIA, 14(7), 2000, pp. 1310-1313
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma
Authors: Martinelli, G Terragna, C Zamagni, E Ronconi, S Tosi, P Lemoli, RM Bandini, G Motta, MR Testoni, N Amabile, M Ottaviani, E Vianelli, N de Vivo, A Gozzetti, A Tura, S Cave, M
Citation: G. Martinelli et al., Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma, J CL ONCOL, 18(11), 2000, pp. 2273-2281
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation
Authors: Martinelli, G Terragna, C Zamagni, E Ronconi, S Tosi, P Lemoli, RM Bandini, G Testoni, N Amabile, M Ottaviani, E Buonamici, S Soverini, S Montefusco, V De Vivo, A Bonifazi, F Tura, S Cavo, M
Citation: G. Martinelli et al., Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation, HAEMATOLOG, 85(9), 2000, pp. 930-934
Clinical outcome of extramedullary plasmacytoma
Authors: Galieni, P Cavo, M Pulsoni, A Avvisati, G Bigazzi, C Neri, S Caliceti, U Benni, M Ronconi, S Lauria, F
Citation: P. Galieni et al., Clinical outcome of extramedullary plasmacytoma, HAEMATOLOG, 85(1), 2000, pp. 47-51
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma
Authors: Cavo, M Terragna, C Martinelli, G Ronconi, S Zamagni, E Tosi, P Lemoli, RM Benni, M Pagliani, G Bandini, G Tura, S
Citation: M. Cavo et al., Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma, BLOOD, 96(1), 2000, pp. 355
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+cells to support singleor tandem high-dose chemotherapy
Authors: Lemoli, RM Martinelli, G Zamagni, E Motta, MR Rizzi, S Terragna, C Rondelli, R Ronconi, S Curti, A Bonifazi, F Tura, S Cavo, M
Citation: Rm. Lemoli et al., Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+cells to support singleor tandem high-dose chemotherapy, BLOOD, 95(7), 2000, pp. 2234-2239
In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells
Authors: Tosi, P Pellacani, A Visani, G Ottaviani, E Ronconi, S Zamagni, E Benni, M Cavo, M Tura, S
Citation: P. Tosi et al., In vitro treatment with retinoids decreases bcl-2 protein expression and enhances dexamethasone-induced cytotoxicity and apoptosis in multiple myeloma cells, EUR J HAEMA, 62(3), 1999, pp. 143-148
Selection and transplantation of autologous CD34(+) B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study
Authors: Lemoli, MR Martinelli, G Olivieri, A Motta, MR Rizzi, S Terragna, C Leopardi, G Benni, M Ronconi, S Cantori, I Rondelli, D Mangianti, S Leoni, P Montanari, M Cavo, M Tura, S
Citation: Mr. Lemoli et al., Selection and transplantation of autologous CD34(+) B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study, BR J HAEM, 107(2), 1999, pp. 419-428
Risultati: 1-9 |